Literature DB >> 29197999

Remote ischemic preconditioning upregulates microRNA-21 to protect the kidney in children with congenital heart disease undergoing cardiopulmonary bypass.

Zhijuan Kang1,2, Zhihui Li3,4, Peng Huang5, Jinwen Luo5, Pingbo Liu5, Ying Wang1,2, Tuanhong Xia1,2, Yuhang Zhou1,2.   

Abstract

BACKGROUND: Acute kidney injury (AKI) is one of the most common emergencies and severe diseases in the clinic. We sought to verify whether remote ischemic preconditioning (RIPC) has a protective effect on the kidney of child with congenital heart disease undergoing cardiopulmonary bypass (CPB) surgery. We hypothesized it may be related to the up-regulation of microRNA-21 (miR-21).
METHODS: We performed a prospective randomized clinical study among children with congenital heart disease undergoing CPB surgery between January and December 2016. Children were randomized to an RIPC or control group. Patients in each group were divided into an AKI and a non-AKI group according to the occurrence of AKI at 48 h after surgery. Remote ischemic preconditioning (RIPC) conducted by blood-pressure cuff was performed 12 h before surgery. Serum creatinine (SCr), tumor necrosis factor-α (TNF-α), and miR-21 expression in blood and urine were measured at different time points.
RESULTS: A total of 449 cases (200 RIPC; 249 controls) were enrolled. The male/female ratio was 1.18, with a mean age of 37.50 ± 25.31 months. The incidence of AKI in the RIPC group was significantly lower than that in the control group (19.0% vs. 46.2%, P<0.01). In further analysis, at 6 h, 24 h, and 48 h after CPB operation, blood TNF-α levels were significantly lower in the RIPC group than in the control group (P<0.01); at 24 h, 48 h, and 72 h, urine TNF-α levels were significantly lower in the RIPC group than in the control group (P<0.05). Urine and blood miR-21 expression in the RIPC group increased significantly, while there was no obvious change in the control group.
CONCLUSIONS: Remote ischemic preconditioning has a protective effect on the kidney in children with congenital heart disease, which may be related with the up-regulation of miR-21 and down-regulating the inflammatory mediator, such as TNF-α.

Entities:  

Keywords:  Acute kidney injury; Cardiopulmonary bypass; Children; Congenital heart disease; MicroRNA-21; Tumor necrosis factor-α

Mesh:

Substances:

Year:  2017        PMID: 29197999     DOI: 10.1007/s00467-017-3851-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  36 in total

Review 1.  Regulation of cardiac and renal ischemia-reperfusion injury by microRNAs.

Authors:  Johan M Lorenzen; Sandor Batkai; Thomas Thum
Journal:  Free Radic Biol Med       Date:  2013-07-08       Impact factor: 7.376

2.  Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status.

Authors:  Xuan Zhou; Yu Ren; Lynette Moore; Mei Mei; Yongping You; Peng Xu; Baoli Wang; Guangxiu Wang; Zhifan Jia; Peiyu Pu; Wei Zhang; Chunsheng Kang
Journal:  Lab Invest       Date:  2010-01-04       Impact factor: 5.662

3.  Elevation of miR-21, through targeting MKK3, may be involved in ischemia pretreatment protection from ischemia-reperfusion induced kidney injury.

Authors:  Zhihui Li; Xu Deng; Zhijuan Kang; Ying Wang; Tuanhong Xia; Niu Ding; Yan Yin
Journal:  J Nephrol       Date:  2015-07-07       Impact factor: 3.902

4.  Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial.

Authors:  Matthias Thielmann; Eva Kottenberg; Petra Kleinbongard; Daniel Wendt; Nilgün Gedik; Susanne Pasa; Vivien Price; Konstantinos Tsagakis; Markus Neuhäuser; Jürgen Peters; Heinz Jakob; Gerd Heusch
Journal:  Lancet       Date:  2013-08-17       Impact factor: 79.321

5.  MicroRNAs in ischemia-reperfusion injury.

Authors:  Jakob Bw Weiss; Steffen U Eisenhardt; G Björn Stark; Christoph Bode; Martin Moser; Sebastian Grundmann
Journal:  Am J Cardiovasc Dis       Date:  2012-07-25

6.  Identification of a microRNA signature of renal ischemia reperfusion injury.

Authors:  Jonathan G Godwin; Xupeng Ge; Kristin Stephan; Anke Jurisch; Stefan G Tullius; John Iacomini
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-22       Impact factor: 11.205

Review 7.  MicroRNA-21 in cardiovascular disease.

Authors:  Yunhui Cheng; Chunxiang Zhang
Journal:  J Cardiovasc Transl Res       Date:  2010-05-01       Impact factor: 4.132

8.  Incidence and outcomes in acute kidney injury: a comprehensive population-based study.

Authors:  Tariq Ali; Izhar Khan; William Simpson; Gordon Prescott; John Townend; William Smith; Alison Macleod
Journal:  J Am Soc Nephrol       Date:  2007-02-21       Impact factor: 10.121

9.  Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells.

Authors:  Lisa B Frankel; Nanna R Christoffersen; Anders Jacobsen; Morten Lindow; Anders Krogh; Anders H Lund
Journal:  J Biol Chem       Date:  2007-11-08       Impact factor: 5.157

10.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.

Authors:  Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  6 in total

Review 1.  MicroRNAs in AKI and Kidney Transplantation.

Authors:  Kristien J Ledeganck; Els M Gielis; Daniel Abramowicz; Peter Stenvinkel; Paul G Shiels; Amaryllis H Van Craenenbroeck
Journal:  Clin J Am Soc Nephrol       Date:  2019-01-02       Impact factor: 8.237

2.  Remote ischemic conditioning in necrotizing enterocolitis: study protocol of a multi-center phase II feasibility randomized controlled trial.

Authors:  Niloofar Ganji; Bo Li; Irfan Ahmad; Alan Daneman; Poorva Deshpande; Vijay Dhar; Simon Eaton; Ricardo Faingold; Estelle B Gauda; Nigel Hall; Salhab El Helou; Mustafa H Kabeer; Jae H Kim; Alice King; Michael H Livingston; Eugene Ng; Martin Offringa; Elena Palleri; Mark Walton; David E Wesson; Tomas Wester; Rene M H Wijnen; Andrew Willan; Rosanna Yankanah; Carlos Zozaya; Prakesh S Shah; Agostino Pierro
Journal:  Pediatr Surg Int       Date:  2022-03-16       Impact factor: 1.827

3.  Strategies to Prevent Acute Kidney Injury after Pediatric Cardiac Surgery: A Network Meta-Analysis.

Authors:  Jef Van den Eynde; Nicolas Cloet; Robin Van Lerberghe; Michel Pompeu B O Sá; Dirk Vlasselaers; Jaan Toelen; Jan Y Verbakel; Werner Budts; Marc Gewillig; Shelby Kutty; Hans Pottel; Djalila Mekahli
Journal:  Clin J Am Soc Nephrol       Date:  2021-10       Impact factor: 10.614

Review 4.  From cerebral ischemia towards myocardial, renal, and hepatic ischemia: Exosomal miRNAs as a general concept of intercellular communication in ischemia-reperfusion injury.

Authors:  Wenqiang Xin; Yafei Qin; Ping Lei; Jianning Zhang; Xinyu Yang; Zengguang Wang
Journal:  Mol Ther Nucleic Acids       Date:  2022-08-24       Impact factor: 10.183

5.  microRNA Expression Levels Change in Neonatal Patients During and After Exposure to Cardiopulmonary Bypass.

Authors:  Lance Hsieh; Lan N Tu; Alison Paquette; Quanhu Sheng; Shilin Zhao; Douglas Bittel; James O'Brien; Kasey Vickers; Peter Pastuszko; Vishal Nigam
Journal:  J Am Heart Assoc       Date:  2022-08-24       Impact factor: 6.106

Review 6.  MicroRNAs as Biomarkers and Therapeutic Targets in Inflammation- and Ischemia-Reperfusion-Related Acute Renal Injury.

Authors:  Yueh-Lin Wu; Hsiao-Fen Li; Hsi-Hsien Chen; Heng Lin
Journal:  Int J Mol Sci       Date:  2020-09-14       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.